|1.||Shanmugavel, M: 2 articles (12/2008 - 06/2007)|
|2.||Feskens, Edith J M: 2 articles (05/2007 - 08/2006)|
|3.||Arts, Ilja C W: 2 articles (05/2007 - 08/2006)|
|4.||Milder, Ivon E J: 2 articles (05/2007 - 08/2006)|
|5.||Hollman, Peter C H: 2 articles (05/2007 - 08/2006)|
|6.||Davin, Laurence B: 2 articles (03/2006 - 04/2005)|
|7.||Moinuddin, Syed G A: 2 articles (03/2006 - 04/2005)|
|8.||Lewis, Norman G: 2 articles (03/2006 - 04/2005)|
|9.||Youn, Buhyun: 2 articles (03/2006 - 04/2005)|
|10.||Smeds, Annika I: 2 articles (02/2006 - 12/2004)|
|1.||Prostatic Neoplasms (Prostate Cancer)
02/11/2010 - "Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis."
04/20/2001 - "Last, both secoisolariciresinol and matairesinol are metabolized in the gut of mammals, following digestion of high fiber dietary grains, seeds, and berries, into the so-called "mammalian" lignans, enterodiol and enterolactone, respectively; these in turn confer significant protection against the onset of breast and prostate cancers."
12/01/2008 - "AP9-cd, a synergistic lignan mixture from Cedrus deodara (Pinaceae) consisting of (-)-wikstromal, (-)-matairesinol and dibenzyl butyrolactol, depicted cytotoxic effects against numerous human cancer cell lines reported previously. "
08/01/2006 - "The intake of matairesinol was inversely associated with mortality due to CHD, CVD, cancer, and all causes. "
08/01/2006 - "However, the intake of matairesinol was inversely associated with CHD, CVD, and all-cause mortality (P </= 0.05 for all) and cancer (P = 0.06). "
02/01/2006 - "AP9-cd, a standardized lignan composition from Cedrus deodara consisting of (-)-wikstromal, (-)-matairesinol, and dibenzyl butyrolactol, showed cytotoxicity in several human cancer cell lines reported earlier. "
06/01/2007 - "An isolate "CD lignan mixture" comprising lignans from stem wood of Cedrus deodara consisted of (-)-wikstromal (75 - 79%), (-)-matairesinol (9 - 13%) and benzylbutyrolactol (7 - 11%) and was studied for its in vitro cytotoxicity against human cancer cell lines. "
|3.||Breast Neoplasms (Breast Cancer)
06/10/2004 - "Breast cancer risk significantly decreased with a high intake of the plant lignan matairesinol (OR = 0.58, 95% CI 0.37-0.94) but not secoisolariciresinol or the sum of plant lignans. "
06/10/2004 - "Our results suggest an important role of dietary intake of daidzein and genistein, despite low levels, as well as of matairesinol and mammalian lignans to reduce premenopausal breast cancer risk in this study population."
03/21/2007 - "We prospectively examined associations between the risk of postmenopausal invasive breast cancer and dietary intakes of four plant lignans (pinoresinol, lariciresinol, secoisolariciresinol, and matairesinol) and estimated exposure to two enterolignans (enterodiol and enterolactone), as measured with a self-administered diet history questionnaire, among 58,049 postmenopausal French women who were not taking soy isoflavone supplements. "
06/28/2013 - "In the present paper, we describe the creation of a dietary analysis database (based on Dietplan6) for the determination of dietary intakes of specific PE (daidzein, genistein, glycitein, formononetin, biochanin A, coumestrol, matairesinol and secoisolariciresinol), in a group of women previously diagnosed and treated for postmenopausal breast cancer. "
|4.||T-Cell Lymphoma (Lymphoma, T Cell)
09/01/2015 - "Our study provides an insight into the potential of arctigenin and matairesinol as good candidates for the development of novel agents against T-cell lymphoma."
09/01/2015 - "Here we investigated the cytotoxicity of arctigenin and matairesinol against a T-cell lymphoma cell line CCRF-CEM and the underlying mechanisms that have not been explored before. "
09/01/2015 - "Cytotoxicity of arctigenin and matairesinol against the T-cell lymphoma cell line CCRF-CEM."